{"id":4913,"date":"2012-12-07T11:59:00","date_gmt":"2012-12-07T08:59:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/sgk-recete-inceleme-biriminden-duyuru\/"},"modified":"2026-01-19T11:09:54","modified_gmt":"2026-01-19T08:09:54","slug":"sgk-recete-inceleme-biriminden-duyuru","status":"publish","type":"post","link":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/","title":{"rendered":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU"},"content":{"rendered":"<div style=\"padding-bottom: 100px; margin: auto; width: 90%; display: flex; justify-content: center; flex-direction: column;\">\n<div>\n SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n SGK Re\u00e7ete \u0130nceleme biriminden g\u00f6revli olan meslekta\u015flar\u0131m\u0131z\u0131n, incelemeden sonra \u00f6deme yapmak i\u00e7in \u00f6rneklemeleri h\u0131zland\u0131rm\u0131\u015f olup Ankara ve Adana SGK \u0130l M\u00fcd\u00fcrl\u00fcklerinden inceleme deste\u011fi al\u0131nm\u0131\u015ft\u0131r. . Ancak a\u015fa\u011f\u0131da g\u00f6r\u00fclen ve bir\u00e7o\u011funun iade edilmek zorunda kal\u0131nd\u0131\u011f\u0131 veya kesintiye&nbsp;neden olarak &nbsp;ma\u011fduriyet ya\u015fanmamas\u0131 i\u00e7in a\u015fa\u011f\u0131da belirtilen hususlar\u0131 hat\u0131rlatma ihtiyac\u0131 do\u011fmu\u015ftur.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <b>1*<\/b> Re\u00e7ete arkas\u0131 bilgilerinin daha \u00f6nceki y\u0131llara g\u00f6re &nbsp;daha d\u00fczenli geldi\u011fi ancak \u00e7ok az say\u0131da baz\u0131 bilgilerin eksik geldi\u011fi(\u0130la\u00e7lar\u0131 alan ki\u015finin bilgileri adres, telefon, T.C, \u0130mza)\n<\/div>\n<div>\n <b>2*<\/b> Medulla provizyon sistemine Dr. Bilgilerinin yanl\u0131\u015f girildi\u011fi\n<\/div>\n<div>\n <b>3*<\/b> Re\u00e7ete dozu rapor dozunu a\u015fmas\u0131 kesintiye neden olmaktad\u0131r.\n<\/div>\n<div>\n <b>4*<\/b> E\u015fde\u011fer ila\u00e7 verilme durumunda yaz\u0131lan ilac\u0131n etken madde\/maddelerinin dozuna dikkat edilmesi gerekti\u011fi( Augmentin&nbsp;600 ile 400 e\u015fde\u011fer de\u011fil, Pediasure plus ile Pediasure sade e\u015fde\u011fer de\u011fil, Augmentin <u>1 gr<\/u> 14 tb&nbsp;ile Augmentin <u>1 gr <\/u>10 tb E\u015fde\u011ferdir. Sistemden e\u015fde\u011fer olarak girilmeyen ila\u00e7lar i\u00e7in \u00e7\u0131kan fark \u00f6rneklemeyle kesintiye neden olmaktad\u0131r.)\n<\/div>\n<div>\n <b>5*<\/b> Rapor kodu ile te\u015fhis kodu uyumlu olmal\u0131d\u0131r.\n<\/div>\n<div>\n \u00d6rnek olarak Te\u015fhis Kodu 04.03-Disritmiler (I44-I45) (I47-I49)\n<\/div>\n<div>\n Raporda Belirtilen ICD 10 Kodu: (I44-I45) veya (I47-I49) aral\u0131klar\u0131nda olmal\u0131d\u0131r.\n<\/div>\n<div>\n <b>6*<\/b> Yatan Hasta re\u00e7etelerinde Ba\u015fhekimlik onay\u0131n\u0131n bulunmad\u0131\u011f\u0131 bunun yerine ba\u015fhekimlik m\u00fchr\u00fcn\u00fcn yap\u0131ld\u0131\u011f\u0131ndan dolay\u0131 iade edildi\u011fi bildirilmi\u015ftir. Mutlaka ba\u015fhekimlik onay\u0131 ve Ba\u015fhekimlik m\u00fchr\u00fc re\u00e7etelerde bulunmas\u0131 gerekmektedir.\n<\/div>\n<div>\n <b>7*<\/b> Klopidogrel (Plavix) kullan\u0131m\u0131nda yap\u0131lan hatan\u0131n; Asa ve Gis intolerans\u0131 mevcuttur ibaresi oldu\u011fu halde Coraspin adl\u0131 ilac\u0131n verildi\u011fi, bu durumda ise Coraspin adl\u0131 ilac\u0131n kesintiye neden oldu\u011fu&nbsp;bildirilmi\u015ftir. Raporda sadece G\u0130S intolerans\u0131 mevcuttur ibaresinin yeterli oldu\u011fu bildirilmi\u015ftir.\n<\/div>\n<div>\n <b>8* <\/b>Kan \u00dcr\u00fcnleri \u0130\u00e7in \u00d6rnek Rapor:\n<\/div>\n<div>\n a- <b><u>Kanama Raporu<\/u><\/b>: Rapor s\u00fcresi 3 g\u00fcnd\u00fcr. Medullaya bu konu ile ilgili olarak yeni te\u015fhis kodu eklendi\u011finden &nbsp;hastan\u0131n elinde ila\u00e7lar\u0131 oldu\u011fu halde sistem \u00f6demektedir.\n<\/div>\n<div>\n Bu te\u015fhis Kodu : 08.01.13.01- Akut kanama ya da cerrahi giri\u015fimler \u00f6ncesi fakt\u00f6r noksanl\u0131klar\u0131na ba\u011fl\u0131 hastal\u0131klar. A\u00e7\u0131klama k\u0131sm\u0131nda ise \u00f6rnek olarak : <span style=\"font-size: 10pt\">SOL AYAK B\u0130LE\u011e\u0130 AKUT HEMARTROZU NEDEN\u0130YLE HEDEF FAKT\u00d6R D\u00dcZEY\u0130N\u0130 %50&#8217;YE \u00c7IKARACAK \u015eEK\u0130LDE 50\u00dc\/KG\/DOZ DAN 3 G\u00dcN KULLANMASI UYGUNDUR. VA: 20KG<\/span>\n<\/div>\n<div>\n b- <b><u>Normal Rapor: <\/u><\/b>&nbsp;&nbsp;&nbsp;<span style=\"font-size: 10pt\">&nbsp;<\/span><b>Fakt\u00f6r D\u00fczeyi %1 ve \u00fczerinde olan hastalarda<\/b>:<span style=\"font-size: 8.5pt; font-weight: normal\">HASTANIN B\u0130R AY\u0130\u00c7\u0130NDE \u00dc\u00c7TEN FAZLA KANMA ATA\u011eI GE\u00c7\u0130RMES\u0130 NEDEN\u0130YLEPROF\u0130LAKS\u0130 PROGRAMINA ALINMI\u015eTIR. MADDE \u0130SM\u0130,KULLANIM DOZU VE ADED\u0130 BEL\u0130RT\u0130LEN HEMOF\u0130L\u0130 A PROF\u0130LAKS\u0130S\u0130 \u0130LE \u0130LG\u0130L\u0130 \u0130LA\u00c7LARI KULLANMASI GEREKMEKTE OLUP HASTA KATILIM PAYINDAN MUAFTIR.HAFTALIK DOZ 4500 \u00dcN\u0130TED\u0130R. YAKLA\u015eIK (20-30 \u00dc\/KG\/G\u00dcN) HAFTADA \u00dc\u00c7 G\u00dcN VER\u0130LECEKT\u0130RFAKT\u00d6R VIII D\u00dcZEY\u0130 %01 HEDEF FAKT\u00d6R D\u00dcZEY\u0130 %20 \u0130NH\u0130B\u0130T\u00d6R D\u00dcZEY\u0130 &#8211; KG:90 1) FAKTOR VIII Parenteral[1X3] Yanl\u0131z 1 (Bir) Kalemdir<\/span>\n<\/div>\n<div>\n <b>Fakt\u00f6r D\u00fczeyi %1 alt\u0131nda&nbsp;olan hastalarda<\/b>: <span style=\"font-size: 8.5pt; font-weight: normal\">HEMOF\u0130L\u0130 A.FAKT\u00d6R D\u00dcZEY\u0130 %0,7 SAPTANDI.\u0130NH\u0130B\u0130T\u00d6R NEGAT\u0130FT\u0130R.HASTA PROF\u0130LAKT\u0130K PROGRAMA ALINMI\u015eTIR. FAKT\u00d6R TEDAV\u0130S\u0130 20-40 U\/KG\/G\u00dcN KULLANMASI UYGUNDUR.(HAFTALIK DOZ 4.500 \u00dcN\u0130TE)<\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n Re\u00e7ete : Kanama re\u00e7etelerinde te\u015fhis olarak kanama oldu\u011fu, di\u011fer durumlarda ise re\u00e7etede profilaksi uyguland\u0131\u011f\u0131 belirtilecektir.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <b>9* <\/b>Kanser raporlar\u0131ndaki k\u00fcr tedavilerinde etken madde k\u00fcr tedavisinde ise ; ka\u00e7 k\u00fcr kullan\u0131laca\u011f\u0131 dozuyla birlikte belirtilmesi gerekmektedir.\n<\/div>\n<div>\n \u00d6rnek: Hasta 2 k\u00fcr Melfalan, 8 k\u00fcr Bortezomid, 4 k\u00fcr talidomid gibi. Her re\u00e7ete 1 k\u00fcrl\u00fck verilecektir. A\u00e7\u0131klama b\u00f6l\u00fcm\u00fcnde ayr\u0131ca di\u011fer bilgiler v\u00fccut y\u00fczey alan\u0131, varsa patoloji merkezin tarih ve numaras\u0131yla birlikte&nbsp;yer almas\u0131 gerekmektedir.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <b>10* <\/b>&nbsp;Desmont, Levmont tb. \u0130\u00e7in \u201cMevsimsel Alerjik Rinit\u201d , \u201cAst\u0131m+Alerjik Rinit\u201d veya \u201cY\u0131l boyu devam eden Alerjik Rinit\u201d te\u015fhislerinden birinin olmas\u0131 yeterli.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <b>11*<\/b> Majistral terkiplerin 10 g\u00fcnl\u00fck dozdan fazla haz\u0131rland\u0131\u011f\u0131 ve alkol \u00e7evirmelerin yap\u0131lmad\u0131\u011f\u0131 g\u00f6r\u00fclmektedir.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n \u00d6rnek 1: Eou de Goulard 1000 cc\n<\/div>\n<div>\n &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S: 3*10 cc\n<\/div>\n<div>\n \u015eeklinde re\u00e7ete edilen bir preperat\u0131n g\u00fcnl\u00fck kullan\u0131m\u0131 30 cc olarak belirtildi\u011finden en fazla 10 g\u00fcnl\u00fck kullan\u0131m olan 300 cc haz\u0131rlanabilir ve hesaplama 300 cc \u00fczerinden yap\u0131l\u0131r.\n<\/div>\n<div>\n Hesaplama: Eau de Goulard Eczac\u0131l\u0131kta kullan\u0131m oran\u0131 %2 Kur\u015fun subasetat i\u00e7erir.\n<\/div>\n<div style=\"text-indent: -39pt; margin: 0in 0in 0pt 57pt\">\n 100<span style=\"font: 7pt 'Times New Roman'\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span>2&nbsp;Kur\u015fun subasetat\n<\/div>\n<div style=\"border-bottom: windowtext 1pt solid; border-left: medium none; padding-bottom: 1pt; padding-left: 0in; padding-right: 0in; margin-left: 0.25in; border-top: medium none; margin-right: 0in; border-right: medium none; padding-top: 0in\">\n<div style=\"border-bottom: medium none; border-left: medium none; padding-bottom: 0in; padding-left: 0in; padding-right: 0in; border-top: medium none; border-right: medium none; padding-top: 0in\">\n  300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; x\n <\/div>\n<\/div>\n<div>\n X= 6 cc Kur\u015fun subasetat&nbsp;kullan\u0131l\u0131r. Eczac\u0131l\u0131kta \u00e7e\u015fme suyu ile haz\u0131rlanan tek preperat oldu\u011fundan kullan\u0131lacak olan \u00e7e\u015fme suyu ise 300-6= 294 cc \u00c7e\u015fme suyu kullan\u0131larak medullada hesaplan\u0131r. <b>Medullada majistral giri\u015f b\u00f6l\u00fcm\u00fcne \u00e7e\u015fme suyu ilave edilmi\u015ftir.<\/b>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n \u00d6rnek 2: Alkol borik % 3 30 cc\n<\/div>\n<div>\n &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S:1*3 cc\n<\/div>\n<div>\n Hesaplama :&nbsp;Preperatta istenilen Alkol derecesi belirtilmemi\u015f ise % 70 lik Alkol kullan\u0131l\u0131r.\n<\/div>\n<div>\n 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 gr&nbsp;Borik asit\n<\/div>\n<div>\n 30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X = 0.9 gr Borik asit\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n Kulland\u0131\u011f\u0131m\u0131z saf alkol\u00fcn derecesi % 96 l\u0131k oldu\u011fundan 30 cc kullan\u0131lacak alkol\u00fc % 70 li\u011fe \u00e7evirmek i\u00e7in\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">96\u00b0 alkolden hareketle 30 ml 70\u00b0 alkol haz\u0131rlanacakt\u0131r..<\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">V1x d 1= V2xd2<\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">V1, :\u0130stenen alkol\u00fcn ml miktar\u0131<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">d1, :\u0130stenen alkol\u00fcn %, h\/h miktar\u0131<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">V2<\/span><span style=\"font-size: 10.5pt\">: Eldeki alkolden al\u0131nmas\u0131 gereken ml miktar\u0131<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">d2: Eldeki alkol\u00fcn %, h\/h miktar\u0131<\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">30&#215;70=V2X96 <\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">V2=<u>30&#215;70<\/u>&nbsp;= 21,875 ml.<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">&nbsp;&nbsp;&nbsp;&nbsp; <\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">21,875 ml % 96 h\/h alkolden al\u0131n\u0131p, ar\u0131t\u0131lm\u0131\u015f su ile mez\u00fcrde 30 ml&#8217;ye<\/span>\n<\/div>\n<div>\n <span style=\"font-size: 10.5pt\">tamamlan\u0131r.<\/span>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n Borik asit :0.9 gr\n<\/div>\n<div>\n Saf alkol : 21,875 ml\n<\/div>\n<div>\n Distile su ile 30 ml tamamlan\u0131r. Medulladan 30-21,875= 8,125 ml distile su olarak hesaplan\u0131r.\n<\/div>\n<div>\n <b>&nbsp;<\/b>\n<\/div>\n<div>\n <b>Not: Yurt d\u0131\u015f\u0131 SSK l\u0131lar\u0131n dosya haz\u0131rlama ve listelenmesi ile ilgili duyuru daha sonra yap\u0131lacakt\u0131r.<\/b>\n<\/div>\n<div>\n <b>&nbsp;<\/b>\n<\/div>\n<div>\n <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ecz.Mehmet F\u0130TK\u0130<\/b>\n<\/div>\n<div>\n <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUT Komisyonu Koordinat\u00f6r\u00fc<\/b>\n<\/div>\n<div>\n <b>&nbsp;<\/b>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU &nbsp; SGK Re\u00e7ete \u0130nceleme biriminden g\u00f6revli olan meslekta\u015flar\u0131m\u0131z\u0131n, incelemeden sonra \u00f6deme yapmak i\u00e7in \u00f6rneklemeleri h\u0131zland\u0131rm\u0131\u015f olup Ankara ve Adana SGK \u0130l M\u00fcd\u00fcrl\u00fcklerinden inceleme deste\u011fi al\u0131nm\u0131\u015ft\u0131r. . Ancak a\u015fa\u011f\u0131da g\u00f6r\u00fclen ve bir\u00e7o\u011funun iade edilmek zorunda kal\u0131nd\u0131\u011f\u0131 veya kesintiye&nbsp;neden olarak &nbsp;ma\u011fduriyet ya\u015fanmamas\u0131 i\u00e7in a\u015fa\u011f\u0131da belirtilen hususlar\u0131 hat\u0131rlatma ihtiyac\u0131 do\u011fmu\u015ftur. &nbsp; 1* Re\u00e7ete arkas\u0131 bilgilerinin daha \u00f6nceki y\u0131llara g\u00f6re &nbsp;daha d\u00fczenli geldi\u011fi ancak \u00e7ok az say\u0131da baz\u0131 bilgilerin eksik geldi\u011fi(\u0130la\u00e7lar\u0131 alan ki\u015finin bilgileri adres, telefon, T.C, \u0130mza) 2* Medulla provizyon sistemine Dr. Bilgilerinin yanl\u0131\u015f girildi\u011fi 3* Re\u00e7ete dozu rapor dozunu a\u015fmas\u0131 kesintiye neden olmaktad\u0131r. 4* E\u015fde\u011fer ila\u00e7 verilme durumunda yaz\u0131lan ilac\u0131n etken madde\/maddelerinin dozuna dikkat edilmesi gerekti\u011fi( Augmentin&nbsp;600 ile 400 e\u015fde\u011fer de\u011fil, Pediasure plus ile Pediasure sade e\u015fde\u011fer de\u011fil, Augmentin 1 gr 14 tb&nbsp;ile Augmentin 1 gr 10 tb E\u015fde\u011ferdir. Sistemden e\u015fde\u011fer olarak girilmeyen ila\u00e7lar i\u00e7in \u00e7\u0131kan fark \u00f6rneklemeyle kesintiye neden olmaktad\u0131r.) 5* Rapor kodu ile te\u015fhis kodu uyumlu olmal\u0131d\u0131r. \u00d6rnek olarak Te\u015fhis Kodu 04.03-Disritmiler (I44-I45) (I47-I49) Raporda Belirtilen ICD 10 Kodu: (I44-I45) veya (I47-I49) aral\u0131klar\u0131nda olmal\u0131d\u0131r. 6* Yatan Hasta re\u00e7etelerinde Ba\u015fhekimlik onay\u0131n\u0131n bulunmad\u0131\u011f\u0131 bunun yerine ba\u015fhekimlik m\u00fchr\u00fcn\u00fcn yap\u0131ld\u0131\u011f\u0131ndan dolay\u0131 iade edildi\u011fi bildirilmi\u015ftir. Mutlaka ba\u015fhekimlik onay\u0131 ve Ba\u015fhekimlik m\u00fchr\u00fc re\u00e7etelerde bulunmas\u0131 gerekmektedir. 7* Klopidogrel (Plavix) kullan\u0131m\u0131nda yap\u0131lan hatan\u0131n; Asa ve Gis intolerans\u0131 mevcuttur ibaresi oldu\u011fu halde Coraspin adl\u0131 ilac\u0131n verildi\u011fi, bu durumda ise Coraspin adl\u0131 ilac\u0131n kesintiye neden oldu\u011fu&nbsp;bildirilmi\u015ftir. Raporda sadece G\u0130S intolerans\u0131 mevcuttur ibaresinin yeterli oldu\u011fu bildirilmi\u015ftir. 8* Kan \u00dcr\u00fcnleri \u0130\u00e7in \u00d6rnek Rapor: a- Kanama Raporu: Rapor s\u00fcresi 3 g\u00fcnd\u00fcr. Medullaya bu konu ile ilgili olarak yeni te\u015fhis kodu eklendi\u011finden &nbsp;hastan\u0131n elinde ila\u00e7lar\u0131 oldu\u011fu halde sistem \u00f6demektedir. Bu te\u015fhis Kodu : 08.01.13.01- Akut kanama ya da cerrahi giri\u015fimler \u00f6ncesi fakt\u00f6r noksanl\u0131klar\u0131na ba\u011fl\u0131 hastal\u0131klar. A\u00e7\u0131klama k\u0131sm\u0131nda ise \u00f6rnek olarak : SOL AYAK B\u0130LE\u011e\u0130 AKUT HEMARTROZU NEDEN\u0130YLE HEDEF FAKT\u00d6R D\u00dcZEY\u0130N\u0130 %50&#8217;YE \u00c7IKARACAK \u015eEK\u0130LDE 50\u00dc\/KG\/DOZ DAN 3 G\u00dcN KULLANMASI UYGUNDUR. VA: 20KG b- Normal Rapor: &nbsp;&nbsp;&nbsp;&nbsp;Fakt\u00f6r D\u00fczeyi %1 ve \u00fczerinde olan hastalarda:HASTANIN B\u0130R AY\u0130\u00c7\u0130NDE \u00dc\u00c7TEN FAZLA KANMA ATA\u011eI GE\u00c7\u0130RMES\u0130 NEDEN\u0130YLEPROF\u0130LAKS\u0130 PROGRAMINA ALINMI\u015eTIR. MADDE \u0130SM\u0130,KULLANIM DOZU VE ADED\u0130 BEL\u0130RT\u0130LEN HEMOF\u0130L\u0130 A PROF\u0130LAKS\u0130S\u0130 \u0130LE \u0130LG\u0130L\u0130 \u0130LA\u00c7LARI KULLANMASI GEREKMEKTE OLUP HASTA KATILIM PAYINDAN MUAFTIR.HAFTALIK DOZ 4500 \u00dcN\u0130TED\u0130R. YAKLA\u015eIK (20-30 \u00dc\/KG\/G\u00dcN) HAFTADA \u00dc\u00c7 G\u00dcN VER\u0130LECEKT\u0130RFAKT\u00d6R VIII D\u00dcZEY\u0130 %01 HEDEF FAKT\u00d6R D\u00dcZEY\u0130 %20 \u0130NH\u0130B\u0130T\u00d6R D\u00dcZEY\u0130 &#8211; KG:90 1) FAKTOR VIII Parenteral[1X3] Yanl\u0131z 1 (Bir) Kalemdir Fakt\u00f6r D\u00fczeyi %1 alt\u0131nda&nbsp;olan hastalarda: HEMOF\u0130L\u0130 A.FAKT\u00d6R D\u00dcZEY\u0130 %0,7 SAPTANDI.\u0130NH\u0130B\u0130T\u00d6R NEGAT\u0130FT\u0130R.HASTA PROF\u0130LAKT\u0130K PROGRAMA ALINMI\u015eTIR. FAKT\u00d6R TEDAV\u0130S\u0130 20-40 U\/KG\/G\u00dcN KULLANMASI UYGUNDUR.(HAFTALIK DOZ 4.500 \u00dcN\u0130TE) &nbsp; Re\u00e7ete : Kanama re\u00e7etelerinde te\u015fhis olarak kanama oldu\u011fu, di\u011fer durumlarda ise re\u00e7etede profilaksi uyguland\u0131\u011f\u0131 belirtilecektir. &nbsp; 9* Kanser raporlar\u0131ndaki k\u00fcr tedavilerinde etken madde k\u00fcr tedavisinde ise ; ka\u00e7 k\u00fcr kullan\u0131laca\u011f\u0131 dozuyla birlikte belirtilmesi gerekmektedir. \u00d6rnek: Hasta 2 k\u00fcr Melfalan, 8 k\u00fcr Bortezomid, 4 k\u00fcr talidomid gibi. Her re\u00e7ete 1 k\u00fcrl\u00fck verilecektir. A\u00e7\u0131klama b\u00f6l\u00fcm\u00fcnde ayr\u0131ca di\u011fer bilgiler v\u00fccut y\u00fczey alan\u0131, varsa patoloji merkezin tarih ve numaras\u0131yla birlikte&nbsp;yer almas\u0131 gerekmektedir. &nbsp; &nbsp; 10* &nbsp;Desmont, Levmont tb. \u0130\u00e7in \u201cMevsimsel Alerjik Rinit\u201d , \u201cAst\u0131m+Alerjik Rinit\u201d veya \u201cY\u0131l boyu devam eden Alerjik Rinit\u201d te\u015fhislerinden birinin olmas\u0131 yeterli. &nbsp; &nbsp; &nbsp; &nbsp; 11* Majistral terkiplerin 10 g\u00fcnl\u00fck dozdan fazla haz\u0131rland\u0131\u011f\u0131 ve alkol \u00e7evirmelerin yap\u0131lmad\u0131\u011f\u0131 g\u00f6r\u00fclmektedir. &nbsp; &nbsp; &nbsp; \u00d6rnek 1: Eou de Goulard 1000 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S: 3*10 cc \u015eeklinde re\u00e7ete edilen bir preperat\u0131n g\u00fcnl\u00fck kullan\u0131m\u0131 30 cc olarak belirtildi\u011finden en fazla 10 g\u00fcnl\u00fck kullan\u0131m olan 300 cc haz\u0131rlanabilir ve hesaplama 300 cc \u00fczerinden yap\u0131l\u0131r. Hesaplama: Eau de Goulard Eczac\u0131l\u0131kta kullan\u0131m oran\u0131 %2 Kur\u015fun subasetat i\u00e7erir. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2&nbsp;Kur\u015fun subasetat 300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; x X= 6 cc Kur\u015fun subasetat&nbsp;kullan\u0131l\u0131r. Eczac\u0131l\u0131kta \u00e7e\u015fme suyu ile haz\u0131rlanan tek preperat oldu\u011fundan kullan\u0131lacak olan \u00e7e\u015fme suyu ise 300-6= 294 cc \u00c7e\u015fme suyu kullan\u0131larak medullada hesaplan\u0131r. Medullada majistral giri\u015f b\u00f6l\u00fcm\u00fcne \u00e7e\u015fme suyu ilave edilmi\u015ftir. &nbsp; \u00d6rnek 2: Alkol borik % 3 30 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S:1*3 cc Hesaplama :&nbsp;Preperatta istenilen Alkol derecesi belirtilmemi\u015f ise % 70 lik Alkol kullan\u0131l\u0131r. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 gr&nbsp;Borik asit 30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X = 0.9 gr Borik asit &nbsp; Kulland\u0131\u011f\u0131m\u0131z saf alkol\u00fcn derecesi % 96 l\u0131k oldu\u011fundan 30 cc kullan\u0131lacak alkol\u00fc % 70 li\u011fe \u00e7evirmek i\u00e7in &nbsp; 96\u00b0 alkolden hareketle 30 ml 70\u00b0 alkol haz\u0131rlanacakt\u0131r.. &nbsp; V1x d 1= V2xd2 &nbsp; V1, :\u0130stenen alkol\u00fcn ml miktar\u0131 d1, :\u0130stenen alkol\u00fcn %, h\/h miktar\u0131 V2: Eldeki alkolden al\u0131nmas\u0131 gereken ml miktar\u0131 d2: Eldeki alkol\u00fcn %, h\/h miktar\u0131 &nbsp; 30&#215;70=V2X96 V2=30&#215;70&nbsp;= 21,875 ml. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 &nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 21,875 ml % 96 h\/h alkolden al\u0131n\u0131p, ar\u0131t\u0131lm\u0131\u015f su ile mez\u00fcrde 30 ml&#8217;ye tamamlan\u0131r. &nbsp; Borik asit :0.9 gr Saf alkol : 21,875 ml Distile su ile 30 ml tamamlan\u0131r. Medulladan 30-21,875= 8,125 ml distile su olarak hesaplan\u0131r. &nbsp; Not: Yurt d\u0131\u015f\u0131 SSK l\u0131lar\u0131n dosya haz\u0131rlama ve listelenmesi ile ilgili duyuru daha sonra yap\u0131lacakt\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUT Komisyonu Koordinat\u00f6r\u00fc &nbsp;<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU &nbsp; SGK Re\u00e7ete \u0130nceleme biriminden g\u00f6revli olan meslekta\u015flar\u0131m\u0131z\u0131n, incelemeden sonra \u00f6deme yapmak i\u00e7in \u00f6rneklemeleri h\u0131zland\u0131rm\u0131\u015f olup Ankara ve Adana SGK \u0130l M\u00fcd\u00fcrl\u00fcklerinden inceleme deste\u011fi al\u0131nm\u0131\u015ft\u0131r. . Ancak a\u015fa\u011f\u0131da g\u00f6r\u00fclen ve bir\u00e7o\u011funun iade edilmek zorunda kal\u0131nd\u0131\u011f\u0131 veya kesintiye&nbsp;neden olarak &nbsp;ma\u011fduriyet ya\u015fanmamas\u0131 i\u00e7in a\u015fa\u011f\u0131da belirtilen hususlar\u0131 hat\u0131rlatma ihtiyac\u0131 do\u011fmu\u015ftur. &nbsp; 1* Re\u00e7ete arkas\u0131 bilgilerinin daha \u00f6nceki y\u0131llara g\u00f6re &nbsp;daha d\u00fczenli geldi\u011fi ancak \u00e7ok az say\u0131da baz\u0131 bilgilerin eksik geldi\u011fi(\u0130la\u00e7lar\u0131 alan ki\u015finin bilgileri adres, telefon, T.C, \u0130mza) 2* Medulla provizyon sistemine Dr. Bilgilerinin yanl\u0131\u015f girildi\u011fi 3* Re\u00e7ete dozu rapor dozunu a\u015fmas\u0131 kesintiye neden olmaktad\u0131r. 4* E\u015fde\u011fer ila\u00e7 verilme durumunda yaz\u0131lan ilac\u0131n etken madde\/maddelerinin dozuna dikkat edilmesi gerekti\u011fi( Augmentin&nbsp;600 ile 400 e\u015fde\u011fer de\u011fil, Pediasure plus ile Pediasure sade e\u015fde\u011fer de\u011fil, Augmentin 1 gr 14 tb&nbsp;ile Augmentin 1 gr 10 tb E\u015fde\u011ferdir. Sistemden e\u015fde\u011fer olarak girilmeyen ila\u00e7lar i\u00e7in \u00e7\u0131kan fark \u00f6rneklemeyle kesintiye neden olmaktad\u0131r.) 5* Rapor kodu ile te\u015fhis kodu uyumlu olmal\u0131d\u0131r. \u00d6rnek olarak Te\u015fhis Kodu 04.03-Disritmiler (I44-I45) (I47-I49) Raporda Belirtilen ICD 10 Kodu: (I44-I45) veya (I47-I49) aral\u0131klar\u0131nda olmal\u0131d\u0131r. 6* Yatan Hasta re\u00e7etelerinde Ba\u015fhekimlik onay\u0131n\u0131n bulunmad\u0131\u011f\u0131 bunun yerine ba\u015fhekimlik m\u00fchr\u00fcn\u00fcn yap\u0131ld\u0131\u011f\u0131ndan dolay\u0131 iade edildi\u011fi bildirilmi\u015ftir. Mutlaka ba\u015fhekimlik onay\u0131 ve Ba\u015fhekimlik m\u00fchr\u00fc re\u00e7etelerde bulunmas\u0131 gerekmektedir. 7* Klopidogrel (Plavix) kullan\u0131m\u0131nda yap\u0131lan hatan\u0131n; Asa ve Gis intolerans\u0131 mevcuttur ibaresi oldu\u011fu halde Coraspin adl\u0131 ilac\u0131n verildi\u011fi, bu durumda ise Coraspin adl\u0131 ilac\u0131n kesintiye neden oldu\u011fu&nbsp;bildirilmi\u015ftir. Raporda sadece G\u0130S intolerans\u0131 mevcuttur ibaresinin yeterli oldu\u011fu bildirilmi\u015ftir. 8* Kan \u00dcr\u00fcnleri \u0130\u00e7in \u00d6rnek Rapor: a- Kanama Raporu: Rapor s\u00fcresi 3 g\u00fcnd\u00fcr. Medullaya bu konu ile ilgili olarak yeni te\u015fhis kodu eklendi\u011finden &nbsp;hastan\u0131n elinde ila\u00e7lar\u0131 oldu\u011fu halde sistem \u00f6demektedir. Bu te\u015fhis Kodu : 08.01.13.01- Akut kanama ya da cerrahi giri\u015fimler \u00f6ncesi fakt\u00f6r noksanl\u0131klar\u0131na ba\u011fl\u0131 hastal\u0131klar. A\u00e7\u0131klama k\u0131sm\u0131nda ise \u00f6rnek olarak : SOL AYAK B\u0130LE\u011e\u0130 AKUT HEMARTROZU NEDEN\u0130YLE HEDEF FAKT\u00d6R D\u00dcZEY\u0130N\u0130 %50&#8217;YE \u00c7IKARACAK \u015eEK\u0130LDE 50\u00dc\/KG\/DOZ DAN 3 G\u00dcN KULLANMASI UYGUNDUR. VA: 20KG b- Normal Rapor: &nbsp;&nbsp;&nbsp;&nbsp;Fakt\u00f6r D\u00fczeyi %1 ve \u00fczerinde olan hastalarda:HASTANIN B\u0130R AY\u0130\u00c7\u0130NDE \u00dc\u00c7TEN FAZLA KANMA ATA\u011eI GE\u00c7\u0130RMES\u0130 NEDEN\u0130YLEPROF\u0130LAKS\u0130 PROGRAMINA ALINMI\u015eTIR. MADDE \u0130SM\u0130,KULLANIM DOZU VE ADED\u0130 BEL\u0130RT\u0130LEN HEMOF\u0130L\u0130 A PROF\u0130LAKS\u0130S\u0130 \u0130LE \u0130LG\u0130L\u0130 \u0130LA\u00c7LARI KULLANMASI GEREKMEKTE OLUP HASTA KATILIM PAYINDAN MUAFTIR.HAFTALIK DOZ 4500 \u00dcN\u0130TED\u0130R. YAKLA\u015eIK (20-30 \u00dc\/KG\/G\u00dcN) HAFTADA \u00dc\u00c7 G\u00dcN VER\u0130LECEKT\u0130RFAKT\u00d6R VIII D\u00dcZEY\u0130 %01 HEDEF FAKT\u00d6R D\u00dcZEY\u0130 %20 \u0130NH\u0130B\u0130T\u00d6R D\u00dcZEY\u0130 &#8211; KG:90 1) FAKTOR VIII Parenteral[1X3] Yanl\u0131z 1 (Bir) Kalemdir Fakt\u00f6r D\u00fczeyi %1 alt\u0131nda&nbsp;olan hastalarda: HEMOF\u0130L\u0130 A.FAKT\u00d6R D\u00dcZEY\u0130 %0,7 SAPTANDI.\u0130NH\u0130B\u0130T\u00d6R NEGAT\u0130FT\u0130R.HASTA PROF\u0130LAKT\u0130K PROGRAMA ALINMI\u015eTIR. FAKT\u00d6R TEDAV\u0130S\u0130 20-40 U\/KG\/G\u00dcN KULLANMASI UYGUNDUR.(HAFTALIK DOZ 4.500 \u00dcN\u0130TE) &nbsp; Re\u00e7ete : Kanama re\u00e7etelerinde te\u015fhis olarak kanama oldu\u011fu, di\u011fer durumlarda ise re\u00e7etede profilaksi uyguland\u0131\u011f\u0131 belirtilecektir. &nbsp; 9* Kanser raporlar\u0131ndaki k\u00fcr tedavilerinde etken madde k\u00fcr tedavisinde ise ; ka\u00e7 k\u00fcr kullan\u0131laca\u011f\u0131 dozuyla birlikte belirtilmesi gerekmektedir. \u00d6rnek: Hasta 2 k\u00fcr Melfalan, 8 k\u00fcr Bortezomid, 4 k\u00fcr talidomid gibi. Her re\u00e7ete 1 k\u00fcrl\u00fck verilecektir. A\u00e7\u0131klama b\u00f6l\u00fcm\u00fcnde ayr\u0131ca di\u011fer bilgiler v\u00fccut y\u00fczey alan\u0131, varsa patoloji merkezin tarih ve numaras\u0131yla birlikte&nbsp;yer almas\u0131 gerekmektedir. &nbsp; &nbsp; 10* &nbsp;Desmont, Levmont tb. \u0130\u00e7in \u201cMevsimsel Alerjik Rinit\u201d , \u201cAst\u0131m+Alerjik Rinit\u201d veya \u201cY\u0131l boyu devam eden Alerjik Rinit\u201d te\u015fhislerinden birinin olmas\u0131 yeterli. &nbsp; &nbsp; &nbsp; &nbsp; 11* Majistral terkiplerin 10 g\u00fcnl\u00fck dozdan fazla haz\u0131rland\u0131\u011f\u0131 ve alkol \u00e7evirmelerin yap\u0131lmad\u0131\u011f\u0131 g\u00f6r\u00fclmektedir. &nbsp; &nbsp; &nbsp; \u00d6rnek 1: Eou de Goulard 1000 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S: 3*10 cc \u015eeklinde re\u00e7ete edilen bir preperat\u0131n g\u00fcnl\u00fck kullan\u0131m\u0131 30 cc olarak belirtildi\u011finden en fazla 10 g\u00fcnl\u00fck kullan\u0131m olan 300 cc haz\u0131rlanabilir ve hesaplama 300 cc \u00fczerinden yap\u0131l\u0131r. Hesaplama: Eau de Goulard Eczac\u0131l\u0131kta kullan\u0131m oran\u0131 %2 Kur\u015fun subasetat i\u00e7erir. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2&nbsp;Kur\u015fun subasetat 300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; x X= 6 cc Kur\u015fun subasetat&nbsp;kullan\u0131l\u0131r. Eczac\u0131l\u0131kta \u00e7e\u015fme suyu ile haz\u0131rlanan tek preperat oldu\u011fundan kullan\u0131lacak olan \u00e7e\u015fme suyu ise 300-6= 294 cc \u00c7e\u015fme suyu kullan\u0131larak medullada hesaplan\u0131r. Medullada majistral giri\u015f b\u00f6l\u00fcm\u00fcne \u00e7e\u015fme suyu ilave edilmi\u015ftir. &nbsp; \u00d6rnek 2: Alkol borik % 3 30 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S:1*3 cc Hesaplama :&nbsp;Preperatta istenilen Alkol derecesi belirtilmemi\u015f ise % 70 lik Alkol kullan\u0131l\u0131r. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 gr&nbsp;Borik asit 30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X = 0.9 gr Borik asit &nbsp; Kulland\u0131\u011f\u0131m\u0131z saf alkol\u00fcn derecesi % 96 l\u0131k oldu\u011fundan 30 cc kullan\u0131lacak alkol\u00fc % 70 li\u011fe \u00e7evirmek i\u00e7in &nbsp; 96\u00b0 alkolden hareketle 30 ml 70\u00b0 alkol haz\u0131rlanacakt\u0131r.. &nbsp; V1x d 1= V2xd2 &nbsp; V1, :\u0130stenen alkol\u00fcn ml miktar\u0131 d1, :\u0130stenen alkol\u00fcn %, h\/h miktar\u0131 V2: Eldeki alkolden al\u0131nmas\u0131 gereken ml miktar\u0131 d2: Eldeki alkol\u00fcn %, h\/h miktar\u0131 &nbsp; 30&#215;70=V2X96 V2=30&#215;70&nbsp;= 21,875 ml. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 &nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 21,875 ml % 96 h\/h alkolden al\u0131n\u0131p, ar\u0131t\u0131lm\u0131\u015f su ile mez\u00fcrde 30 ml&#8217;ye tamamlan\u0131r. &nbsp; Borik asit :0.9 gr Saf alkol : 21,875 ml Distile su ile 30 ml tamamlan\u0131r. Medulladan 30-21,875= 8,125 ml distile su olarak hesaplan\u0131r. &nbsp; Not: Yurt d\u0131\u015f\u0131 SSK l\u0131lar\u0131n dosya haz\u0131rlama ve listelenmesi ile ilgili duyuru daha sonra yap\u0131lacakt\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUT Komisyonu Koordinat\u00f6r\u00fc &nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-07T08:59:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:09:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU\",\"datePublished\":\"2012-12-07T08:59:00+00:00\",\"dateModified\":\"2026-01-19T08:09:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/\"},\"wordCount\":1235,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/\",\"name\":\"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2012-12-07T08:59:00+00:00\",\"dateModified\":\"2026-01-19T08:09:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/12\\\/07\\\/sgk-recete-inceleme-biriminden-duyuru\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/","og_locale":"tr_TR","og_type":"article","og_title":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU &nbsp; SGK Re\u00e7ete \u0130nceleme biriminden g\u00f6revli olan meslekta\u015flar\u0131m\u0131z\u0131n, incelemeden sonra \u00f6deme yapmak i\u00e7in \u00f6rneklemeleri h\u0131zland\u0131rm\u0131\u015f olup Ankara ve Adana SGK \u0130l M\u00fcd\u00fcrl\u00fcklerinden inceleme deste\u011fi al\u0131nm\u0131\u015ft\u0131r. . Ancak a\u015fa\u011f\u0131da g\u00f6r\u00fclen ve bir\u00e7o\u011funun iade edilmek zorunda kal\u0131nd\u0131\u011f\u0131 veya kesintiye&nbsp;neden olarak &nbsp;ma\u011fduriyet ya\u015fanmamas\u0131 i\u00e7in a\u015fa\u011f\u0131da belirtilen hususlar\u0131 hat\u0131rlatma ihtiyac\u0131 do\u011fmu\u015ftur. &nbsp; 1* Re\u00e7ete arkas\u0131 bilgilerinin daha \u00f6nceki y\u0131llara g\u00f6re &nbsp;daha d\u00fczenli geldi\u011fi ancak \u00e7ok az say\u0131da baz\u0131 bilgilerin eksik geldi\u011fi(\u0130la\u00e7lar\u0131 alan ki\u015finin bilgileri adres, telefon, T.C, \u0130mza) 2* Medulla provizyon sistemine Dr. Bilgilerinin yanl\u0131\u015f girildi\u011fi 3* Re\u00e7ete dozu rapor dozunu a\u015fmas\u0131 kesintiye neden olmaktad\u0131r. 4* E\u015fde\u011fer ila\u00e7 verilme durumunda yaz\u0131lan ilac\u0131n etken madde\/maddelerinin dozuna dikkat edilmesi gerekti\u011fi( Augmentin&nbsp;600 ile 400 e\u015fde\u011fer de\u011fil, Pediasure plus ile Pediasure sade e\u015fde\u011fer de\u011fil, Augmentin 1 gr 14 tb&nbsp;ile Augmentin 1 gr 10 tb E\u015fde\u011ferdir. Sistemden e\u015fde\u011fer olarak girilmeyen ila\u00e7lar i\u00e7in \u00e7\u0131kan fark \u00f6rneklemeyle kesintiye neden olmaktad\u0131r.) 5* Rapor kodu ile te\u015fhis kodu uyumlu olmal\u0131d\u0131r. \u00d6rnek olarak Te\u015fhis Kodu 04.03-Disritmiler (I44-I45) (I47-I49) Raporda Belirtilen ICD 10 Kodu: (I44-I45) veya (I47-I49) aral\u0131klar\u0131nda olmal\u0131d\u0131r. 6* Yatan Hasta re\u00e7etelerinde Ba\u015fhekimlik onay\u0131n\u0131n bulunmad\u0131\u011f\u0131 bunun yerine ba\u015fhekimlik m\u00fchr\u00fcn\u00fcn yap\u0131ld\u0131\u011f\u0131ndan dolay\u0131 iade edildi\u011fi bildirilmi\u015ftir. Mutlaka ba\u015fhekimlik onay\u0131 ve Ba\u015fhekimlik m\u00fchr\u00fc re\u00e7etelerde bulunmas\u0131 gerekmektedir. 7* Klopidogrel (Plavix) kullan\u0131m\u0131nda yap\u0131lan hatan\u0131n; Asa ve Gis intolerans\u0131 mevcuttur ibaresi oldu\u011fu halde Coraspin adl\u0131 ilac\u0131n verildi\u011fi, bu durumda ise Coraspin adl\u0131 ilac\u0131n kesintiye neden oldu\u011fu&nbsp;bildirilmi\u015ftir. Raporda sadece G\u0130S intolerans\u0131 mevcuttur ibaresinin yeterli oldu\u011fu bildirilmi\u015ftir. 8* Kan \u00dcr\u00fcnleri \u0130\u00e7in \u00d6rnek Rapor: a- Kanama Raporu: Rapor s\u00fcresi 3 g\u00fcnd\u00fcr. Medullaya bu konu ile ilgili olarak yeni te\u015fhis kodu eklendi\u011finden &nbsp;hastan\u0131n elinde ila\u00e7lar\u0131 oldu\u011fu halde sistem \u00f6demektedir. Bu te\u015fhis Kodu : 08.01.13.01- Akut kanama ya da cerrahi giri\u015fimler \u00f6ncesi fakt\u00f6r noksanl\u0131klar\u0131na ba\u011fl\u0131 hastal\u0131klar. A\u00e7\u0131klama k\u0131sm\u0131nda ise \u00f6rnek olarak : SOL AYAK B\u0130LE\u011e\u0130 AKUT HEMARTROZU NEDEN\u0130YLE HEDEF FAKT\u00d6R D\u00dcZEY\u0130N\u0130 %50&#8217;YE \u00c7IKARACAK \u015eEK\u0130LDE 50\u00dc\/KG\/DOZ DAN 3 G\u00dcN KULLANMASI UYGUNDUR. VA: 20KG b- Normal Rapor: &nbsp;&nbsp;&nbsp;&nbsp;Fakt\u00f6r D\u00fczeyi %1 ve \u00fczerinde olan hastalarda:HASTANIN B\u0130R AY\u0130\u00c7\u0130NDE \u00dc\u00c7TEN FAZLA KANMA ATA\u011eI GE\u00c7\u0130RMES\u0130 NEDEN\u0130YLEPROF\u0130LAKS\u0130 PROGRAMINA ALINMI\u015eTIR. MADDE \u0130SM\u0130,KULLANIM DOZU VE ADED\u0130 BEL\u0130RT\u0130LEN HEMOF\u0130L\u0130 A PROF\u0130LAKS\u0130S\u0130 \u0130LE \u0130LG\u0130L\u0130 \u0130LA\u00c7LARI KULLANMASI GEREKMEKTE OLUP HASTA KATILIM PAYINDAN MUAFTIR.HAFTALIK DOZ 4500 \u00dcN\u0130TED\u0130R. YAKLA\u015eIK (20-30 \u00dc\/KG\/G\u00dcN) HAFTADA \u00dc\u00c7 G\u00dcN VER\u0130LECEKT\u0130RFAKT\u00d6R VIII D\u00dcZEY\u0130 %01 HEDEF FAKT\u00d6R D\u00dcZEY\u0130 %20 \u0130NH\u0130B\u0130T\u00d6R D\u00dcZEY\u0130 &#8211; KG:90 1) FAKTOR VIII Parenteral[1X3] Yanl\u0131z 1 (Bir) Kalemdir Fakt\u00f6r D\u00fczeyi %1 alt\u0131nda&nbsp;olan hastalarda: HEMOF\u0130L\u0130 A.FAKT\u00d6R D\u00dcZEY\u0130 %0,7 SAPTANDI.\u0130NH\u0130B\u0130T\u00d6R NEGAT\u0130FT\u0130R.HASTA PROF\u0130LAKT\u0130K PROGRAMA ALINMI\u015eTIR. FAKT\u00d6R TEDAV\u0130S\u0130 20-40 U\/KG\/G\u00dcN KULLANMASI UYGUNDUR.(HAFTALIK DOZ 4.500 \u00dcN\u0130TE) &nbsp; Re\u00e7ete : Kanama re\u00e7etelerinde te\u015fhis olarak kanama oldu\u011fu, di\u011fer durumlarda ise re\u00e7etede profilaksi uyguland\u0131\u011f\u0131 belirtilecektir. &nbsp; 9* Kanser raporlar\u0131ndaki k\u00fcr tedavilerinde etken madde k\u00fcr tedavisinde ise ; ka\u00e7 k\u00fcr kullan\u0131laca\u011f\u0131 dozuyla birlikte belirtilmesi gerekmektedir. \u00d6rnek: Hasta 2 k\u00fcr Melfalan, 8 k\u00fcr Bortezomid, 4 k\u00fcr talidomid gibi. Her re\u00e7ete 1 k\u00fcrl\u00fck verilecektir. A\u00e7\u0131klama b\u00f6l\u00fcm\u00fcnde ayr\u0131ca di\u011fer bilgiler v\u00fccut y\u00fczey alan\u0131, varsa patoloji merkezin tarih ve numaras\u0131yla birlikte&nbsp;yer almas\u0131 gerekmektedir. &nbsp; &nbsp; 10* &nbsp;Desmont, Levmont tb. \u0130\u00e7in \u201cMevsimsel Alerjik Rinit\u201d , \u201cAst\u0131m+Alerjik Rinit\u201d veya \u201cY\u0131l boyu devam eden Alerjik Rinit\u201d te\u015fhislerinden birinin olmas\u0131 yeterli. &nbsp; &nbsp; &nbsp; &nbsp; 11* Majistral terkiplerin 10 g\u00fcnl\u00fck dozdan fazla haz\u0131rland\u0131\u011f\u0131 ve alkol \u00e7evirmelerin yap\u0131lmad\u0131\u011f\u0131 g\u00f6r\u00fclmektedir. &nbsp; &nbsp; &nbsp; \u00d6rnek 1: Eou de Goulard 1000 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S: 3*10 cc \u015eeklinde re\u00e7ete edilen bir preperat\u0131n g\u00fcnl\u00fck kullan\u0131m\u0131 30 cc olarak belirtildi\u011finden en fazla 10 g\u00fcnl\u00fck kullan\u0131m olan 300 cc haz\u0131rlanabilir ve hesaplama 300 cc \u00fczerinden yap\u0131l\u0131r. Hesaplama: Eau de Goulard Eczac\u0131l\u0131kta kullan\u0131m oran\u0131 %2 Kur\u015fun subasetat i\u00e7erir. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2&nbsp;Kur\u015fun subasetat 300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; x X= 6 cc Kur\u015fun subasetat&nbsp;kullan\u0131l\u0131r. Eczac\u0131l\u0131kta \u00e7e\u015fme suyu ile haz\u0131rlanan tek preperat oldu\u011fundan kullan\u0131lacak olan \u00e7e\u015fme suyu ise 300-6= 294 cc \u00c7e\u015fme suyu kullan\u0131larak medullada hesaplan\u0131r. Medullada majistral giri\u015f b\u00f6l\u00fcm\u00fcne \u00e7e\u015fme suyu ilave edilmi\u015ftir. &nbsp; \u00d6rnek 2: Alkol borik % 3 30 cc &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S:1*3 cc Hesaplama :&nbsp;Preperatta istenilen Alkol derecesi belirtilmemi\u015f ise % 70 lik Alkol kullan\u0131l\u0131r. 100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 gr&nbsp;Borik asit 30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X = 0.9 gr Borik asit &nbsp; Kulland\u0131\u011f\u0131m\u0131z saf alkol\u00fcn derecesi % 96 l\u0131k oldu\u011fundan 30 cc kullan\u0131lacak alkol\u00fc % 70 li\u011fe \u00e7evirmek i\u00e7in &nbsp; 96\u00b0 alkolden hareketle 30 ml 70\u00b0 alkol haz\u0131rlanacakt\u0131r.. &nbsp; V1x d 1= V2xd2 &nbsp; V1, :\u0130stenen alkol\u00fcn ml miktar\u0131 d1, :\u0130stenen alkol\u00fcn %, h\/h miktar\u0131 V2: Eldeki alkolden al\u0131nmas\u0131 gereken ml miktar\u0131 d2: Eldeki alkol\u00fcn %, h\/h miktar\u0131 &nbsp; 30&#215;70=V2X96 V2=30&#215;70&nbsp;= 21,875 ml. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 &nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 21,875 ml % 96 h\/h alkolden al\u0131n\u0131p, ar\u0131t\u0131lm\u0131\u015f su ile mez\u00fcrde 30 ml&#8217;ye tamamlan\u0131r. &nbsp; Borik asit :0.9 gr Saf alkol : 21,875 ml Distile su ile 30 ml tamamlan\u0131r. Medulladan 30-21,875= 8,125 ml distile su olarak hesaplan\u0131r. &nbsp; Not: Yurt d\u0131\u015f\u0131 SSK l\u0131lar\u0131n dosya haz\u0131rlama ve listelenmesi ile ilgili duyuru daha sonra yap\u0131lacakt\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUT Komisyonu Koordinat\u00f6r\u00fc &nbsp;","og_url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2012-12-07T08:59:00+00:00","article_modified_time":"2026-01-19T08:09:54+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"6 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#article","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU","datePublished":"2012-12-07T08:59:00+00:00","dateModified":"2026-01-19T08:09:54+00:00","mainEntityOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/"},"wordCount":1235,"commentCount":0,"publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/","name":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#primaryimage"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2012-12-07T08:59:00+00:00","dateModified":"2026-01-19T08:09:54+00:00","breadcrumb":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#primaryimage","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/12\/07\/sgk-recete-inceleme-biriminden-duyuru\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/urfaeo.kolaysoft.com.tr\/"},{"@type":"ListItem","position":2,"name":"SGK RE\u00c7ETE \u0130NCELEME B\u0130R\u0130M\u0130NDEN DUYURU"}]},{"@type":"WebSite","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urfaeo.kolaysoft.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=4913"}],"version-history":[{"count":0,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4913\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=4913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=4913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=4913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}